NAV
$75.50
AUM
$1.0B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.94
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +8.84% | +2.47% | +6.12% | +19.27% | +16.61% | +8.85% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.72% |
| 2 | HSBA.L | HSBC Holdings PLC | 1.43% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.31% |
| 4 | AZN.L | AstraZeneca PLC | 1.24% |
| 5 | NOVN.SW | Novartis AG Registered Shares | 1.21% |
| 6 | NESN.SW | Nestle SA | 1.16% |
| 7 | SHEL.L | Shell PLC | 1.04% |
| 8 | FTOXX | Goldman Sachs FS Treasury Obligs Instl | 1.02% |
| 9 | SIE.DE | Siemens AG | 1.00% |
The fund invests at least 80% of its assets in securities included in its underlying index, in depositary receipts representing securities included in its underlying index and in underlying stocks in respect of depositary receipts included in its underlying index. The index consists of equity securities of large and mid-capitalization issuers covering approximately the largest 85% of the free-float market capitalization in developed markets excluding North America.
Inception Date: 2020-05-12